CURRENT ISSUE HIGHLIGHTS

Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib

Published online March 31, 2026

Increasingly, therapeutic advancements in dermatology favor targeted modalities, such as monoclonal antibodies and biologic therapies, ...

Published online March 31, 2026

Exosomes are extracellular vesicles released by cells that transfer proteins, lipids, mRNAs, and microRNAs to recipient cells playing a...

Published online March 31, 2026

Post-inflammatory hyperpigmentation (PIH) is a common acquired condition resulting from an overproduction of melanin or abnormal deposi...

Published online March 31, 2026

Hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation, solar lentigines, and drug-induced pigmentation are c...

Published online March 30, 2026

Psoriasis is a chronic inflammatory skin condition, affecting approximately three percent of the United States population. While modern...

Published online March 30, 2026

Acne vulgaris is one of the most common chronic dermatologic conditions globally and often significantly affects quality of life. For m...

Published online March 30, 2026

In recent years, there has been a notable increase in attention to and financial support for dermatology. 1,2 Skin conditions now rank...

Published online March 30, 2026

Nail disorders encompass a broad spectrum of infectious, inflammatory, neoplastic, and traumatic conditions that may present with overl...

Published online March 30, 2026

Hyperhidrosis (HH) is defined as excessive sweating beyond the physiologic requirements of thermoregulation. 1 HH is classified as eit...

Published online March 30, 2026

Dermatoporosis is a term first coined by Kaya and Saurat in 2007, describing progressive skin thinning, extracellular matrix (ECM) degr...

Published online March 30, 2026

The United States Medical Licensing Examination (USMLE) will stop reporting a 3-digit numerical score and begin reporting a pass/fail o...

Published online March 26, 2026

Chronic spontaneous urticaria (CSU) is a chronic, debilitating condition characterized by recurrent wheals and/or angioedema. 1 Sympto...

Published online March 25, 2026

Vitiligo is a chronic autoimmune skin disorder characterized by progressive loss of epidermal melanocytes, resulting in depigmented mac...

Published online March 25, 2026

In the United States (US), the incidence of melanoma, the most aggressive and fatal type of skin cancer, has been increasing at an aver...

Published online March 25, 2026

Lichen Planus (LP) is an auto-inflammatory idiopathic condition with unclear etiology, believed to be an auto-reactive response of T-ce...

Published online March 24, 2026

Seborrheic dermatitis (SD) is a chronic, relapsing inflammatory condition. SD affects areas that are rich in sebaceous glands, most com...

Published online March 13, 2026

Over-the-counter (OTC) products are often used as firstline or adjunctive treatments for many dermatologic conditions. 1,2 Topical for...

Published online March 13, 2026

To the Editor, Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are widely prescribed for type 2 diabetes and, more recently, for obesity man...

Current Issue

Explore JDDonline

Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Rapid Clearance of Lichen Planus With Topical Tapinarof

Mikaela Sonis | Featured Articles, Latest News, Medical Derm | No Comments

Topical tapinarof associated with rapid resolution of shin lichen planus in a treatment resistant patient This is a must-read case report in JDD. The report describes a 70-year-old woman with…

Journal of Drugs in Dermatology JDD Article about Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata

Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata

Mikaela Sonis | Alopecia, Featured Articles, Latest News | No Comments

A practical review of efficacy, safety, and real world considerations for advanced practice providers This is a must-read JDD article on JAK inhibitors for alopecia areata. The review summarizes current…

Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?

JDD Re:View With Dr. Beer

Mikaela Sonis | Aesthetics, Alopecia, Featured Articles, Hair, JDD Re:View, Latest News | No Comments

Hair Disorders and Treatments Hair treatments have proliferated in the past several years. While prior treatment options were limited to topical minoxidil and oral finasteride for androgenetic alopecia (AGA),…

Proximal Subungual Onychomycosis in the Immunocompetent: A Case Report and Review of the Literature

Mikaela Sonis | Featured Articles, Latest News, Nails | No Comments

From the Vault: Pulled due to increased interest in rare onychomycosis presentations This case report dates back to JDD’s April 2018 issue. It’s a case report describing a healthy 51-year-old…

Journal of Drugs in Dermatology JDD Article about Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

Mikaela Sonis | Featured Articles, Latest News, Psoriasis | No Comments

Updated long term and real world evidence on efficacy and safety This is a must-read JDD article on brodalumab in plaque psoriasis. The review summarizes long term clinical trial findings,…

View all Derm News

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

CURRENT ISSUE HIGHLIGHTS

Published online March 31, 2026

Published online March 31, 2026

Increasingly, therapeutic advancements in dermatology favor targeted modalities, such as monoclonal antibodies and biologic therapies, ...

Published online March 31, 2026

Exosomes are extracellular vesicles released by cells that transfer proteins, lipids, mRNAs, and microRNAs to recipient cells playing a...

Published online March 31, 2026

Post-inflammatory hyperpigmentation (PIH) is a common acquired condition resulting from an overproduction of melanin or abnormal deposi...

Published online March 31, 2026

Hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation, solar lentigines, and drug-induced pigmentation are c...

Published online March 30, 2026

Psoriasis is a chronic inflammatory skin condition, affecting approximately three percent of the United States population. While modern...

Published online March 30, 2026

Acne vulgaris is one of the most common chronic dermatologic conditions globally and often significantly affects quality of life. For m...

Published online March 30, 2026

In recent years, there has been a notable increase in attention to and financial support for dermatology. 1,2 Skin conditions now rank...

Published online March 30, 2026

Nail disorders encompass a broad spectrum of infectious, inflammatory, neoplastic, and traumatic conditions that may present with overl...

Published online March 30, 2026

Hyperhidrosis (HH) is defined as excessive sweating beyond the physiologic requirements of thermoregulation. 1 HH is classified as eit...

Published online March 30, 2026

Dermatoporosis is a term first coined by Kaya and Saurat in 2007, describing progressive skin thinning, extracellular matrix (ECM) degr...

Published online March 30, 2026

The United States Medical Licensing Examination (USMLE) will stop reporting a 3-digit numerical score and begin reporting a pass/fail o...

Published online March 26, 2026

Chronic spontaneous urticaria (CSU) is a chronic, debilitating condition characterized by recurrent wheals and/or angioedema. 1 Sympto...

Published online March 25, 2026

Vitiligo is a chronic autoimmune skin disorder characterized by progressive loss of epidermal melanocytes, resulting in depigmented mac...

Published online March 25, 2026

In the United States (US), the incidence of melanoma, the most aggressive and fatal type of skin cancer, has been increasing at an aver...

Published online March 25, 2026

Lichen Planus (LP) is an auto-inflammatory idiopathic condition with unclear etiology, believed to be an auto-reactive response of T-ce...

Published online March 24, 2026

Seborrheic dermatitis (SD) is a chronic, relapsing inflammatory condition. SD affects areas that are rich in sebaceous glands, most com...

Published online March 13, 2026

Over-the-counter (OTC) products are often used as firstline or adjunctive treatments for many dermatologic conditions. 1,2 Topical for...

Published online March 13, 2026

To the Editor, Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are widely prescribed for type 2 diabetes and, more recently, for obesity man...

Explore JDDonline

Latest News

News Topics

JDD Newsletter

JDD Podcast

Follow Us

jddonline

News Topics

Journal of Drugs in Dermatology

Search